Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
1. Kent Lake PR opposes Quanterix's merger with Akoya Biosciences. 2. They hold 7.7% of Quanterix and filed a proxy statement.
1. Kent Lake PR opposes Quanterix's merger with Akoya Biosciences. 2. They hold 7.7% of Quanterix and filed a proxy statement.
Historically, shareholder opposition can lead to delayed or rejected mergers, impacting stock performance negatively.
The opposition by a significant shareholder could shift shareholder sentiment and affect stock price.
The immediate reaction may drive stock fluctuations due to uncertainty about the merger's future.